Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

459.00 -3.58 (-0.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 995,206
Open 462.50
Bid (Size) 450.05 (10)
Ask (Size) 460.60 (2)
Prev. Close 462.58
Today's Range 457.36 - 469.55
52wk Range 377.85 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
Via The Motley Fool
The Ultimate Healthcare Stock to Buy With $500 Right Now
Via The Motley Fool

Performance

YTD
+13.12%
+13.12%
1 Month
+10.08%
+10.08%
3 Month
-1.72%
-1.72%
6 Month
-5.95%
-5.95%
1 Year
+8.72%
+8.72%

More News

Read More
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Via The Motley Fool
Exposures Product Safety
Moderna (MRNA) Q4 Earnings Report Preview: What To Look For
Via StockStory
Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
Via The Motley Fool
This NXP Semiconductors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Vertex Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results
Via Benzinga
Vertex: Strong Sales, Stronger Pipeline
Via The Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.
Via Investor's Business Daily
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
Via StockStory
Vertex Pharma Stock Flooded With Price-Target Hikes After Upbeat Q4 Revenue, 2025 Outlook: Retail Stays Bullish
Via Stocktwits
Markets Steady, Positive; Q4 Earnings Keep Rolling
Via Talk Markets
Topics Government Stocks / Equities World Trade
Exposures Political Tariff
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Vertex's Revenue Surges but EPS Slips
Via The Motley Fool
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 Sales Top Estimates
Via StockStory
Vertex Reports Fourth Quarter and Full Year 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
Via Benzinga
Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings
Via Benzinga
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
Via Benzinga
Topics World Trade
Exposures Tariff
Earnings Scheduled For February 10, 2025
Via Benzinga
McDonald's, ON Semiconductor And 3 Stocks To Watch Heading Into Monday
Via Benzinga
2 Biotech Stocks to Buy Hand Over Fist in February
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For
Via StockStory
UnitedHealth, Vertex Pharmaceuticals, Axon Enterprise And A Major Energy Stock: CNBC's 'Final Trades'
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.